BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 35048499)

  • 1. New PET/CT criterion for predicting lymph node metastasis in resectable advanced (stage IB-III) lung cancer: The standard uptake values ratio of ipsilateral/contralateral hilar nodes.
    Kameyama K; Imai K; Ishiyama K; Takashima S; Kuriyama S; Atari M; Ishii Y; Kobayashi A; Takahashi S; Kobayashi M; Harata Y; Sato Y; Motoyama S; Hashimoto M; Nomura K; Minamiya Y
    Thorac Cancer; 2022 Mar; 13(5):708-715. PubMed ID: 35048499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New PET/CT criterion for nodal staging in non-small cell lung cancer: measurement of the ratio of section area of standard uptake values ≥2.5/lymph node section area.
    Saito Y; Imai K; Ishiyama K; Saito H; Motoyama S; Sato Y; Konno H; Fujishima S; Hashimoto M; Minamiya Y
    Gen Thorac Cardiovasc Surg; 2017 Jun; 65(6):350-357. PubMed ID: 28229271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ratio of Lymph Node to Primary Tumor SUV on PET/CT Accurately Predicts Nodal Malignancy in Non-Small-Cell Lung Cancer.
    Mattes MD; Moshchinsky AB; Ahsanuddin S; Rizk NP; Foster A; Wu AJ; Ashamalla H; Weber WA; Rimner A
    Clin Lung Cancer; 2015 Nov; 16(6):e253-8. PubMed ID: 26163919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of (11)C-choline PET/CT and enhanced CT in the evaluation of patients with pulmonary abnormalities and locoregional lymph node involvement in lung cancer.
    Peng Z; Liu Q; Li M; Han M; Yao S; Liu Q
    Clin Lung Cancer; 2012 Jul; 13(4):312-20. PubMed ID: 22182444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fusion positron emission/computed tomography underestimates the presence of hilar nodal metastases in patients with resected non-small cell lung cancer.
    Carrillo SA; Daniel VC; Hall N; Hitchcock CL; Ross P; Kassis ES
    Ann Thorac Surg; 2012 May; 93(5):1621-4. PubMed ID: 22429676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preoperative intrathoracic lymph node staging in patients with non-small-cell lung cancer: accuracy of integrated positron emission tomography and computed tomography.
    Billé A; Pelosi E; Skanjeti A; Arena V; Errico L; Borasio P; Mancini M; Ardissone F
    Eur J Cardiothorac Surg; 2009 Sep; 36(3):440-5. PubMed ID: 19464906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New CT criteria for nodal staging in non-small cell lung cancer.
    Kudo S; Imai K; Ishiyama K; Hashimoto M; Saito H; Motoyama S; Sato Y; Takashima S; Murata K; Minamiya Y
    Clin Imaging; 2014; 38(4):448-453. PubMed ID: 24651060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Node/aorta and node/liver SUV ratios from (18)F-FDG PET/CT may improve the detection of occult mediastinal lymph node metastases in patients with non-small cell lung carcinoma.
    Kuo WH; Wu YC; Wu CY; Ho KC; Chiu PH; Wang CW; Chang CJ; Yu CT; Yen TC; Lin C
    Acad Radiol; 2012 Jun; 19(6):685-92. PubMed ID: 22459646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Density and SUV ratios from PET/CT in the detection of mediastinal lymph node metastasis in non-small cell lung cancer].
    Shao T; Yu L; Li Y; Chen M
    Zhongguo Fei Ai Za Zhi; 2015 Mar; 18(3):155-60. PubMed ID: 25800571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrated FDG-PET/CT does not make invasive staging of the intrathoracic lymph nodes in non-small cell lung cancer redundant: a prospective study.
    Tournoy KG; Maddens S; Gosselin R; Van Maele G; van Meerbeeck JP; Kelles A
    Thorax; 2007 Aug; 62(8):696-701. PubMed ID: 17687098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implications of false negative and false positive diagnosis in lymph node staging of NSCLC by means of ¹⁸F-FDG PET/CT.
    Li S; Zheng Q; Ma Y; Wang Y; Feng Y; Zhao B; Yang Y
    PLoS One; 2013; 8(10):e78552. PubMed ID: 24205256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of preoperative PET-CT in assessing mediastinal and hilar lymph node status in early stage lung cancer.
    Lin WY; Hsu WH; Lin KH; Wang SJ
    J Chin Med Assoc; 2012 May; 75(5):203-8. PubMed ID: 22632985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor-to-liver standard uptake ratio using fluorine-18 fluorodeoxyglucose positron emission tomography computed tomography effectively predict occult lymph node metastasis of non-small cell lung cancer patients.
    Shi YM; Niu R; Shao XL; Zhang FF; Shao XN; Wang JF; Wang XS; Liu B; Yu WJ; Wang YT
    Nucl Med Commun; 2020 May; 41(5):459-468. PubMed ID: 32187163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The maximum standardized uptake value of fluorodeoxyglucose positron emission tomography of the primary tumour is a good predictor of pathological nodal involvement in clinical N0 non-small-cell lung cancer.
    Miyasaka Y; Suzuki K; Takamochi K; Matsunaga T; Oh S
    Eur J Cardiothorac Surg; 2013 Jul; 44(1):83-7. PubMed ID: 23233074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of integrated positron emission tomography and computed tomography accuracy in detecting lymph node metastasis in patients with adenocarcinoma vs squamous cell carcinoma.
    Billè A; Okiror L; Skanjeti A; Errico L; Arena V; Penna D; Ardissone F; Pelosi E
    Eur J Cardiothorac Surg; 2013 Mar; 43(3):574-9. PubMed ID: 22689182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Limitations of PET/CT in the Detection of Occult N1 Metastasis in Clinical Stage I(T1-2aN0) Non-Small Cell Lung Cancer for Staging Prior to Stereotactic Body Radiotherapy.
    Akthar AS; Ferguson MK; Koshy M; Vigneswaran WT; Malik R
    Technol Cancer Res Treat; 2017 Feb; 16(1):15-21. PubMed ID: 26792491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The additional value of FDG PET imaging for distinguishing N0 or N1 from N2 stage in preoperative staging of non-small cell lung cancer in region where the prevalence of inflammatory lung disease is high.
    Turkmen C; Sonmezoglu K; Toker A; Yilmazbayhan D; Dilege S; Halac M; Erelel M; Ece T; Mudun A
    Clin Nucl Med; 2007 Aug; 32(8):607-12. PubMed ID: 17667432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Occult mediastinal lymph node metastasis in FDG-PET/CT node-negative lung adenocarcinoma patients: Risk factors and histopathological study.
    Miao H; Shaolei L; Nan L; Yumei L; Shanyuan Z; Fangliang L; Yue Y
    Thorac Cancer; 2019 Jun; 10(6):1453-1460. PubMed ID: 31127706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective preoperative mediastinal lymph node staging by integrated positron emission tomography-computerised tomography in patients with non-small-cell lung cancer.
    Perigaud C; Bridji B; Roussel JC; Sagan C; Mugniot A; Duveau D; Baron O; Despins P
    Eur J Cardiothorac Surg; 2009 Oct; 36(4):731-6. PubMed ID: 19632852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of integrated positron emission tomography and computed tomography in the assessment of nodal spread in cases with non-small cell lung cancer.
    Tasci E; Tezel C; Orki A; Akin O; Falay O; Kutlu CA
    Interact Cardiovasc Thorac Surg; 2010 Feb; 10(2):200-3. PubMed ID: 19933240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.